Amy L Body

5PUBLICATIONS
13CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 02, 2026
Type II RAF Inhibitor Tovorafenib in Recurrent/Refractory Melanoma or Other Solid Tumors With BRAF Fusions or CRAF/RAF1 Fusions or Amplification: Phase II FIRELIGHT-1 Substudy.

|Dec 23, 2022
Rapid Protocol Development, Study Startup and Enrolment of a Prospective Study of COVID-19 Vaccination for Patients with Cancer: A Collaborative Approach.

Amy Body, Vivienne Milch, Lynda McSorley

|Jan 21, 2022
Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET).

Amy Body, Elizabeth Ahern, Luxi Lal

|Oct 11, 2020
Use and outcomes of chemotherapy for metastatic pancreatic cancer in Australia.

Amy Body, Rachel Wong, Jeremy Shapiro

Pageof 1

Frequent Collaborators

1 joint publications

Rachel Wong

1 joint publications

Vivienne Milch

1 joint publications

Eva Segelov

1 joint publications

Maria Vieito